Bradsaude stock
Price history
+37.49% over the period1 year: from R$11.95 (November 13, 2025) to R$16.43 (November 13, 2026), +37.49%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | R$16.43 |
| October 30, 2026 | R$14.10 |
| September 30, 2026 | R$13.35 |
| August 31, 2026 | R$13.87 |
| July 31, 2026 | R$15.92 |
| June 30, 2026 | R$14.38 |
| May 29, 2026 | R$13.56 |
| April 30, 2026 | R$15.25 |
| March 31, 2026 | R$13.43 |
| February 27, 2026 | R$14.64 |
| January 30, 2026 | R$11.24 |
| December 30, 2025 | R$11.20 |
| November 28, 2025 | R$11.60 |
| November 13, 2025 | R$11.95 |
At a glance
The company
Provides private dental care plans and related healthcare services to corporate and individual customers in Brazil
Latest results
Quarter to September 30, 2026 · EPS R$0.37 (estimate R$0.34)
TickerLandia's take on Bradsaude
- Priced as usual relative to earnings: P/E on the latest fiscal year 15 vs a median of 17 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 11 vs 18 (−37%) in a group of 7.
- Strong point: Market momentum (91/100 in its group). Weak point: Earnings stability (41/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−0.84% from the 52-week high
Analysts · 12 analysts
Average targetR$18.09+10.09% vs. price
Buy 11 · Hold 1 · Sell 0 · Strong buy
TickerLandia Fingerprint: Bradsaude
Compared with similar companies: very strong momentum and very high dividend.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 317 Latin American stocks.
Pricelow27
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 11.5 11 Forward P/E 9.47 11 EV/EBITDA 9.17 21 Price/book 2.42 29 Price/sales 2.08 63 Profitabilityhigh72
How much it earns on revenue and capital.
Metric Value Position in group ROE 20.0% 80 ROA 10.1% 92 Gross margin 24.9% 42 Net margin 9.1% 74 Operating margin 16.0% 72 Earnings stabilityaverage41
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.2% 24 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthhigh74
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +9.14% 38 Revenue growth (year over year) +1,856.80% 99 Earnings growth (year over year) +54.80% 85 Financial strengthhigh79
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.11 47 Net debt/EBITDAcounts in reverse: lower means more financial strength 0.00 89 Debt/equitycounts in reverse: lower means more financial strength 0.01 90 Interest coverage 20.9 89 Dividendvery high81
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 19 years 65 Payout ratio 71.9% 84 Dividend yield 4.6% 93 Market momentumvery strong91
How the stock has moved compared with the market.
Metric Value Position in group Distance from 200-day average +15.73% 92 Relative strength (3 months) +16.03% 89 Relative strength (6 months) +21.38% 94 1-year return +37.49% 87 Riskaverage49
How much the price swings.
Metric Value Position in group Volatility (60 days) 50.7% 73 Beta (1 year) 0.95 44 Maximum drawdown (12 months) 21.2% 29
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Bradsaude is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Bradsaude's P/E today is 15.4, in line with the median of its last 10 fiscal years (17.3; between 10.5 and 31.5 from 2016 to 2025). Bradsaude's P/E (trailing 12 months): 11.5, −37% against the median of a group of 7 similar companies (18.3).
Compared with 7 similar companies
| Metric | Bradsaude | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 11.5 | Low | |
| Forward P/E | 9.47 | Low | |
| Operating margin | 16.0% | High | |
| ROE | 20.0% | High | |
| Debt/equity | 0.01 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Bradsaude. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Net income
R$1.18B
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- R$47.62B
- P/E
- 11.5
- EPS
- R$1.42
- Volume
- 0
- Daily trading
- €16.84M
- Dividend yield
- 4.78%
- Last ex-dividend on November 3, 2026
How Bradsaude is changing
All resultsRevenue grew 6.2% a year on average over the last 5 years
Operating margin rose from 29.1% to 35.1%
Profits turn into cash: free cash flow equal to 93% of net income
Returns
Bradsaude returns with dividends
R$1,000 invested in Bradsaude 5 years ago, on November 16, 2021, would be worth R$1,842 today with dividends reinvested: +84.24% in total, +13.02% per year. On price alone it would be R$1,328 (+32.79%).
| Period | Bradsaude | Ibovespa | R$1,000 becomes |
|---|---|---|---|
| 1 month | +3.01% | −16.64% | R$1,030 |
| 6 months | +18.20% | −2.62% | R$1,182 |
| Year to date | +46.70% | +7.03% | R$1,467 |
| 1 year | +48.46% | +9.73% | R$1,485 |
| 3 years | +81.52% | +43.27% | R$1,815 |
| 5 years | +84.24% | +65.02% | R$1,842 |
| 10 years | +158.30% | +189.08% | R$2,583 |
Over the last 6 months it has done better than 60% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Ibovespa: with dividends. Calculate your investment
The chart in detail
Bradsaude: technical analysis
Bradsaude is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 1.9% below its all-time closing high (R$16.75, January 23, 2020).
- Trend
- Upward
- RSI (14 sessions)
- 62
- Between 30 and 70
- vs 200-session average
- +15.73%
Support and resistance
Price areas where Bradsaude has stopped several times in the last year. They describe the chart; they are not forecasts.
- ResistanceR$16.56+0.79%2 touches, last on October 25, 2026
- Last priceR$16.43
- SupportR$16.21−1.32%4 touches, last on October 9, 2026
- SupportR$15.67−4.66%2 touches, last on September 11, 2026
- SupportR$14.22−13.43%3 touches, last on August 18, 2026
Volatility and risk
Over the last year it has moved roughly in line with the Ibovespa.
- Beta (1 year) vs Ibovespa
- 0.95
- Volatility (60 sessions, annualised)
- 50.7%
- Largest fall in the last year
- −21.24%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Bradsaude: seasonality
Average monthly price change over 20 years
Over the last 20 years, the strongest month for Bradsaude has been January: +2.30% on average, positive in 12 years out of 20. The weakest has been August: −1.17% on average, positive in 8 years out of 20. November, the current month, has been positive in 11 years out of 19 (+0.60% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +2.30% | +3.94% | 12 of 20 |
| February | +1.26% | +0.12% | 10 of 20 |
| March | +0.02% | −0.30% | 9 of 20 |
| April | +1.23% | −0.05% | 10 of 20 |
| May | +2.04% | +3.30% | 12 of 20 |
| June | +1.44% | −0.76% | 9 of 20 |
| July | +1.66% | +0.98% | 10 of 20 |
| August | −1.17% | −1.82% | 8 of 20 |
| September | +1.35% | +0.83% | 11 of 20 |
| October | +0.67% | −2.53% | 8 of 20 |
| November | +0.60% | +1.60% | 11 of 19 |
| December | +1.27% | +1.02% | 12 of 19 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Bradsaude and its competitors
Bradsaude SA sells its private dental care plans across Brazil, offering them to companies and individuals. Its activity is split into corporate clients, small and medium-sized enterprises, individual subscribers and other clients. Beyond managing and selling plans, the group provides consulting and business management, licenses software, trades in healthcare products and pharmaceutical inputs, and offers specialised services linked to accidents and illnesses, along with actuarial and risk management work.
- Headquarters
- Barueri, Brazil
- Employees
- 1,957
- Founded
- 1987
- Chief executive
- Carlos Alberto Marinelli
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| BradsaudeSAUD3 | $8.41B | 16.0% | 11.5 | +18.20% |
| CenteneCNC | $33.52B | 1.9% | 22.8 | +21.19% |
| HumanaHUM | $54.05B | 1.8% | 43.3 | +47.61% |
| The Cigna GroupCI | $78.26B | 3.8% | 13.1 | −1.23% |
| Elevance HealthELV | $92.88B | 4.0% | 18.3 | +7.52% |
| CVS HealthCVS | $114.32B | 3.1% | 10.4 | −8.93% |
Same industry or related industries, similar size. Compare Bradsaude with its competitors · Full profile